Testing the Combination of Anti-cancer Drugs Tiragolumab and Atezolizumab to Improve Outcomes for Patients With Recurrent Glioblastoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Weill Medical College of Cornell University
University of Utah
University of Iowa
Phoenix Molecular Imaging
Jonsson Comprehensive Cancer Center
Northwestern University